Since 2004, the Quantitative Imaging Workshop focuses on the advancement of quantitative low-dose computerized tomography (LDCT) imaging biomarkers for detection and management of early thoracic disease—lung cancer, COPD and cardiovascular disease—three of the top four leading causes of death in the U.S.
Beginning in 2013, each year at the Workshop the Prevent Cancer Foundation® presents the James L. Mulshine, M.D., International Leadership Award to an individual who has had a profound impact on reducing the toll these diseases take on the health of Americans and individuals around the world.
The 2023 James L. Mulshine, M.D., International Leadership Award honored Professor Matthijs Oudkerk, M.D., Ph.D., for his role as a co-principal investigator of the NELSON randomized screening trial. The NELSON trials successfully demonstrated the mortality benefit of lung cancer screening for Europe and led to the recognition of lung cancer screening by 27 nations as a recommended cancer detection service for 750 million individuals.
Past recipients of this award include:
- 2022 – Andrea B. McKee, M.D. and the late Brady J. McKee, M.D. for their contributions to ensuring community hospitals and cancer centers provide equitable access to the highest quality screenings and their instrumental involvement in developing the LungRADS system.
- 2021 – Mary Pasquinelli, DNP, APRN, FNP-BC, CTTS, for her work to advance lung cancer screening through patient care, research, and publication.
- 2020 – Daniel C. Sullivan, M.D. for his work in founding and chairing the Quantitative Imaging Biomarkers Alliance (QIBA). QIBA is committed to transforming patient care by making radiology a more quantitative science.
- 2019 – Andrew C. von Eschenbach, M.D., Director, National Cancer Institute, for his design, implementation and management of the largest and most expensive clinical trial in its history, the National Lung Screening Trial (NLST)
- 2018 – Sharon Y. Eubanks, U.S. Department of Justice, for her work as the lead Justice Department prosecutor in the landmark racketeering trial against Big Tobacco, a case which defied predictions and was won by the government
- 2017 – The late John Walsh, President and CEO of the COPD Foundation and President and Founder of the Alpha One Foundation
- 2016 – Laurie Fenton Ambrose, President and CEO of the Lung Cancer Alliance, for her efforts to guide patient advocacy groups in successful efforts to gain coverage of lung cancer screening by the Centers for Medicare & Medicaid Services (CMS)
- 2015 – Claudia Henschke, Ph.D., M.D., Mt. Sinai Medical Center, as a pioneer of the use of low-dose spiral CT to screen for lung cancer
- 2014 – CVS Health, award accepted by Nancy Gagliano, M.D., CVS Chief Medical Officer, in recognition of the company’s bold decision to discontinue the sale of tobacco products in their stores
- 2013 (Inaugural year of the Award) – Cheryl G. Healton, Ph.D., President and CEO, Legacy Foundation and Dean of the College of Public Health at New York University, in recognition of over 25 years of tireless work in public health, specifically on tobacco control
